A new nanoparticle may improve the effectiveness of chemotherapy for children with neuroblastoma.
The non-toxic nanoparticle delivers nitric oxide to specific cancer cells.
Researchers found neuroblastoma cells treated with the nanoparticle needed only one-fifth the dose of chemotherapy, meaning fewer detrimental side effects to surrounding healthy cells.
The next step is to test the nanoparticle on other cell lines, such as lung and colon cancer cells, and to proceed to in vivo tests.
Read more at UNSW Sydney